Galderma Standardizes on Medidata Rave for Global Dermatology Trials
Medidata Solutions
today announced that
Galderma
has standardized on the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) platform.
Based in Lausanne, Switzerland with a presence in 65 countries, Galderma operates one of the world’s largest R&D facilities dedicated exclusively to developing treatments for dermatological conditions. These state-of-the-art laboratories, located in Sophia Antipolis, France, are complemented by development centers in Princeton, New Jersey and Tokyo, Japan. With an ongoing need to conduct an expanding number of global clinical trials, Galderma’s data management team conducted an extensive, six-month evaluation of three vendors before selecting Medidata Solutions.
“Medidata’s track record executing global trials across all trial phases, coupled with their professionalism, proactivity and responsiveness, was critical to our rollout of the Rave solution,” said Francis Gon, head of Global Data Management at Galderma. “Medidata’s training and eLearning tools also made it easy for us to take the solution in-house and begin to independently build and execute studies in any phase and in multiple languages.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.
